Literature DB >> 20880566

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Andrew Rosa Borges1, Lindsay Wieczorek, Benitra Johnson, Alan J Benesi, Bruce K Brown, Richard D Kensinger, Fred C Krebs, Brian Wigdahl, Robert Blumenthal, Anu Puri, Francine E McCutchan, Deborah L Birx, Victoria R Polonis, Cara-Lynne Schengrund.   

Abstract

Specific glycosphingolipids (GSL), found on the surface of target immune cells, are recognized as alternate cell surface receptors by the human immunodeficiency virus type 1 (HIV-1) external envelope glycoprotein. In this study, the globotriose and 3'-sialyllactose carbohydrate head groups found on two GSL were covalently attached to a dendrimer core to produce two types of unique multivalent carbohydrates (MVC). These MVC inhibited HIV-1 infection of T cell lines and primary peripheral blood mononuclear cells (PBMC) by T cell line-adapted viruses or primary isolates, with IC(50)s ranging from 0.1 to 7.4 μg/ml. Inhibition of Env-mediated membrane fusion by MVC was also observed using a dye-transfer assay. These carbohydrate compounds warrant further investigation as a potential new class of HIV-1 entry inhibitors. The data presented also shed light on the role of carbohydrate moieties in HIV-1 virus-host cell interactions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880566      PMCID: PMC2966527          DOI: 10.1016/j.virol.2010.09.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  73 in total

1.  Association between GM3 and CD4-Ick complex in human peripheral blood lymphocytes.

Authors:  M Sorice; T Garofalo; R Misasi; A Longo; J Mikulak; V Dolo; G M Pontieri; A Pavan
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

2.  Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions.

Authors:  D Hammache; G Piéroni; M Maresca; S Ivaldi; N Yahi; J Fantini
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.

Authors:  P I Kitov; J M Sadowska; G Mulvey; G D Armstrong; H Ling; N S Pannu; R J Read; D R Bundle
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

4.  Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion.

Authors:  J Fantini; M Maresca; D Hammache; N Yahi; O Delézay
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

5.  Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion.

Authors:  A Puri; P Hug; K Jernigan; P Rose; R Blumenthal
Journal:  Biosci Rep       Date:  1999-08       Impact factor: 3.840

6.  Syntheses of the L-manno and some other analogs of the terminal determinants of the O-PS of Vibrio cholerae O:1.

Authors:  E Poirot; X Zhang; N F Whittaker; P Kovác
Journal:  Carbohydr Res       Date:  2001-01-15       Impact factor: 2.104

7.  CD77: an antigen of germinal center B cells entering apoptosis.

Authors:  M Mangeney; Y Richard; D Coulaud; T Tursz; J Wiels
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

8.  Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.

Authors:  P Hug; H M Lin; T Korte; X Xiao; D S Dimitrov; J M Wang; A Puri; R Blumenthal
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.

Authors:  Z L Jonak; R K Clark; D Matour; S Trulli; R Craig; E Henri; E V Lee; R Greig; C Debouck
Journal:  AIDS Res Hum Retroviruses       Date:  1993-01       Impact factor: 2.205

10.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Authors:  J M Harouse; S Bhat; S L Spitalnik; M Laughlin; K Stefano; D H Silberberg; F Gonzalez-Scarano
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

View more
  13 in total

Review 1.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.

Authors:  Russell Clayton; Janee Hardman; Celia C LaBranche; Katherine D McReynolds
Journal:  Bioconjug Chem       Date:  2011-09-06       Impact factor: 4.774

4.  Cell delivery of therapeutic nanoparticles.

Authors:  JoEllyn McMillan; Elena Batrakova; Howard E Gendelman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.

Authors:  Cara-Lynne Schengrund
Journal:  Adv Neurobiol       Date:  2023

6.  Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes.

Authors:  Mélanie Merbah; Sayali Onkar; Jean-Charles Grivel; Christophe Vanpouille; Angélique Biancotto; Lydia Bonar; Eric Sanders-Buell; Gustavo Kijak; Nelson Michael; Merlin Robb; Jerome H Kim; Sodsai Tovanabutra; Agnès-Laurence Chenine
Journal:  J Virol Methods       Date:  2016-01-22       Impact factor: 2.014

Review 7.  Nanoparticle-based drug delivery to the vagina: a review.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-05-14       Impact factor: 9.776

Review 8.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

Review 9.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

Review 10.  Recent advances in engineering polyvalent biological interactions.

Authors:  Chad T Varner; Tania Rosen; Jacob T Martin; Ravi S Kane
Journal:  Biomacromolecules       Date:  2014-11-26       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.